Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0006142 (
breast cancer
)
160,383
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
With great interest, we read the recent article entitled "Association between BRIP1 (
BACH1
) polymorphisms and
breast cancer
risk: a meta-analysis" published online in Pabalan et al. (
Breast Cancer
Res Treat 137:553-558, 2013). This article suggests that overall summary estimates imply no associations but suggest susceptibility among carriers of the C47G polymorphism and Pro-Ser genotype in premenopausal women. The result is encouraging. Nevertheless, several key issues in this meta-analysis are worth noticing.
Breast Cancer
Res Treat 2015 Apr
PMID:Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk. 2322 46
BACH1
(BTB and CNC homology 1, basic leucine zipper transcription factor 1) is a transcriptional factor and a member of cap 'n' collar (CNC) and basic region leucine zipper factor family. In contrast to other bZIP family members,
BACH1
appeared as a comparatively specific transcription factor. It acts as transcription regulator and is recognized as a recently hypoxia regulator and functions as an inducible repressor for the HO-1 gene in many human cell types in response to stress oxidative. In regard to studies lately, although,
BACH1
has been related to the regulation of oxidative stress and heme oxidation, it has never been linked to invasion and metastasis. Recent studies have showed that
BACH1
is involved in bone metastasis of
breast cancer
by up-regulating vital metastatic genes like CXCR4 and MMP1. This newly discovered aspect of
BACH1
gene provides new insight into cancer progression study and stands on its master regulator role in metastasis process, raising the possibility of considering it as a potential target for cancer therapy.
...
PMID:BACH1, the master regulator gene: A novel candidate target for cancer therapy. 2710 4
<< Previous
1
2
3
4